Back to today’s briefing

Story perspectives

Professor Innovates Ovarian Cancer Treatment with New Therapies

1/23/2025

48 5

Summary

Story summary

Professor Udai Banerji is pioneering groundbreaking research at the Institute of Cancer Research, targeting ovarian cancer with a powerful duo: avutometinib and defactinib. His innovative approach champions personalized therapies and advanced IL-12 immunotherapy delivery methods, striving to overcome funding hurdles and ignite hope for better treatment options in the fight against this devastating disease.

1 of 1

Story summary

Professor Udai Banerji is pioneering groundbreaking research at the Institute of Cancer Research, targeting ovarian cancer with a powerful duo: avutometinib and defactinib. His innovative approach champions personalized therapies and advanced IL-12 immunotherapy delivery methods, striving to overcome funding hurdles and ignite hope for better treatment options in the fight against this devastating disease.